ORCID

Abstract

Large scale genetic studies such as genome-wide association studies (GWAS) in Parkinson's disease (PD) have revealed genetic susceptibility factors and continue to offer new insights both into the genetics of sporadic disease and its pathogenesis, with the potential for identification of an at-risk population and novel therapeutic targets. However, the methodology importantly requires larger data sets for replication of novel findings.

DOI

10.1136/jnnp-2013-306573.136

Publication Date

2013-11-01

Publication Title

J Neurol Neurosurg Psychiatry

Volume

84

Issue

11

Organisational Unit

Peninsula Medical School

Keywords

["PARKINSON'S DISEASE", STROKE

Share

COinS